Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Palermo

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Current Cancer Drug Targets|March 6, 2012
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyondA Ballestrero, A Garuti, G Cirmena, et al.
Current Research in Toxicology|March 5, 2025
Evaluation of the endocrine disrupting potential of Di-isodecyl phthalateI A Lea, D Feifarek, A Mihalchik, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|June 23, 2011
Terahertz oscillations in ultra-thin n-In(0.53)Ga(0.47)As ungated channelsJ-F Millithaler, L Reggiani, J Pousset, et al.
American Journal of Hypertension|September 12, 2000
Nitric oxide and salt sensitivityL X Cubeddu, A B Alfieri, I S Hoffmann, et al.
Oncogene|May 7, 2013
Heparanase promotes lymphangiogenesis and tumor invasion in pancreatic neuroendocrine tumorsK E Hunter, C Palermo, J C Kester, et al.
European Review for Medical and Pharmacological Sciences|September 23, 2020
Duchenne muscular dystrophy: preliminary experience with sacubitril-valsartan in patients with asymptomatic left ventricular dysfunctionP Lamendola, G A Lanza, V Melita, et al.
Current Research in Toxicology|March 17, 2025
Evaluation of the endocrine disrupting potential of Di-isononyl phthalateI A Lea, A N Buerger, D Feifarek, et al.
Current Research in Toxicology|June 18, 2025
Corrigendum to "Evaluation of the Endocrine Disrupting Potential of Di-isononyl Phthalate" [Curr. Res. Toxicol. 8 (2025) 100220]I A Lea, A N Buerger, D Feifarek, et al.
European Journal of Medicinal Chemistry|November 26, 2002
Preparation and anticoagulant activity of the phosphosulfomannan PI-88Guangli Yu, Nur Sibel Gunay, Robert J Linhardt, et al.
Neuromuscular Disorders : NMD|July 2, 2013
Six minute walk test in type III spinal muscular atrophy: a 12month longitudinal studyE Mazzone, F Bianco, M Main, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Current Cancer Drug Targets|March 6, 2012
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyondA Ballestrero, A Garuti, G Cirmena, et al.
Current Research in Toxicology|March 5, 2025
Evaluation of the endocrine disrupting potential of Di-isodecyl phthalateI A Lea, D Feifarek, A Mihalchik, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|June 23, 2011
Terahertz oscillations in ultra-thin n-In(0.53)Ga(0.47)As ungated channelsJ-F Millithaler, L Reggiani, J Pousset, et al.
American Journal of Hypertension|September 12, 2000
Nitric oxide and salt sensitivityL X Cubeddu, A B Alfieri, I S Hoffmann, et al.
Oncogene|May 7, 2013
Heparanase promotes lymphangiogenesis and tumor invasion in pancreatic neuroendocrine tumorsK E Hunter, C Palermo, J C Kester, et al.
European Review for Medical and Pharmacological Sciences|September 23, 2020
Duchenne muscular dystrophy: preliminary experience with sacubitril-valsartan in patients with asymptomatic left ventricular dysfunctionP Lamendola, G A Lanza, V Melita, et al.
Current Research in Toxicology|March 17, 2025
Evaluation of the endocrine disrupting potential of Di-isononyl phthalateI A Lea, A N Buerger, D Feifarek, et al.
Current Research in Toxicology|June 18, 2025
Corrigendum to "Evaluation of the Endocrine Disrupting Potential of Di-isononyl Phthalate" [Curr. Res. Toxicol. 8 (2025) 100220]I A Lea, A N Buerger, D Feifarek, et al.
European Journal of Medicinal Chemistry|November 26, 2002
Preparation and anticoagulant activity of the phosphosulfomannan PI-88Guangli Yu, Nur Sibel Gunay, Robert J Linhardt, et al.
Neuromuscular Disorders : NMD|July 2, 2013
Six minute walk test in type III spinal muscular atrophy: a 12month longitudinal studyE Mazzone, F Bianco, M Main, et al.
Pageof 6